ATE221208T1 - VERFAHREN ZUR ßIN-VIVOß-MESSUNG DER KONZENTRATION VON XENOBIOTISCHEN VERBINDUNGEN MITTELS MAGNETISCHER KERNRESONANZ - Google Patents

VERFAHREN ZUR ßIN-VIVOß-MESSUNG DER KONZENTRATION VON XENOBIOTISCHEN VERBINDUNGEN MITTELS MAGNETISCHER KERNRESONANZ

Info

Publication number
ATE221208T1
ATE221208T1 AT94302820T AT94302820T ATE221208T1 AT E221208 T1 ATE221208 T1 AT E221208T1 AT 94302820 T AT94302820 T AT 94302820T AT 94302820 T AT94302820 T AT 94302820T AT E221208 T1 ATE221208 T1 AT E221208T1
Authority
AT
Austria
Prior art keywords
concentration
magnetic resonance
ßin
vivoß
measuring
Prior art date
Application number
AT94302820T
Other languages
English (en)
Inventor
Michael F Tweedle
Harry William Strauss
Adrian D Nunn
Original Assignee
Bracco Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Int Bv filed Critical Bracco Int Bv
Application granted granted Critical
Publication of ATE221208T1 publication Critical patent/ATE221208T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/448—Relaxometry, i.e. quantification of relaxation times or spin density
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94302820T 1993-04-23 1994-04-20 VERFAHREN ZUR ßIN-VIVOß-MESSUNG DER KONZENTRATION VON XENOBIOTISCHEN VERBINDUNGEN MITTELS MAGNETISCHER KERNRESONANZ ATE221208T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/052,959 US5468467A (en) 1993-04-23 1993-04-23 Methods for the in vivo measurement of the concentration of non-imaging nmr-detectable xenobiotic compounds

Publications (1)

Publication Number Publication Date
ATE221208T1 true ATE221208T1 (de) 2002-08-15

Family

ID=21981033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94302820T ATE221208T1 (de) 1993-04-23 1994-04-20 VERFAHREN ZUR ßIN-VIVOß-MESSUNG DER KONZENTRATION VON XENOBIOTISCHEN VERBINDUNGEN MITTELS MAGNETISCHER KERNRESONANZ

Country Status (15)

Country Link
US (2) US5468467A (de)
EP (1) EP0621491B1 (de)
JP (1) JPH07374A (de)
KR (1) KR100359898B1 (de)
CN (1) CN1094938A (de)
AT (1) ATE221208T1 (de)
AU (1) AU6061394A (de)
CA (1) CA2119345C (de)
CZ (1) CZ89894A3 (de)
DE (1) DE69431016T2 (de)
FI (1) FI941832A7 (de)
HU (1) HUT69795A (de)
IL (1) IL109115A (de)
NO (1) NO941485L (de)
ZA (1) ZA942781B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753207A (en) * 1995-08-21 1998-05-19 Beth Israel Deaconess Medical Center, Inc. Use of paramagnetic compounds to measure temperature and pH in vivo
EP0890114A1 (de) * 1996-03-29 1999-01-13 Lawrence Berkeley National Laboratory Verbesserung von kermagnetischer resonanz und bilderzeugung durch kermagnetische resonanz im beisein von hyperpolarisierten edelgasen
US6319678B1 (en) * 1998-06-26 2001-11-20 Panvera Corporation Process for glucuronidation screening
US20040146847A1 (en) * 1998-12-07 2004-07-29 Trubetskoy Olga V. Process for glucuronidation screening
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
DE10230877A1 (de) * 2002-07-09 2004-02-12 Siemens Ag Kernspintomographiegerät mit einer Einrichtung zur graphischen Planung Kontrastmittel-gestützter angiographischer Messungen
ES2369903T3 (es) * 2003-01-23 2011-12-09 University Of Florida Research Foundation, Incorporated Método y aparato para la vertificación de la concentración intravenosa (iv) de fármacos usando aliento exhalado.
US7939058B2 (en) * 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
US20080085563A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of Gadolinium Chelates
US20080085562A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of gadolinium chelates
KR100973063B1 (ko) * 2008-11-11 2010-07-29 경희대학교 산학협력단 층상 가돌리늄 히드록사이드 및 그를 포함하는 ｍｒｉ 조영제
JP5971677B2 (ja) * 2010-11-26 2016-08-17 東芝メディカルシステムズ株式会社 磁気共鳴診断装置、および、磁気共鳴スペクトロスコピーのデータ収集方法
US10159413B2 (en) 2012-02-08 2018-12-25 Anatech Advanced Nmr Algorithms Technologies Ltd. Apparatus and method for non-invasive measurement of blood parameters
CA2870876C (en) * 2012-05-23 2019-10-01 Genentech, Inc. Selection method for therapeutic agents
CN103217530B (zh) * 2013-03-26 2015-01-28 南昌大学 一种基于顺磁纳米Fe-Co合金探针间接富集的NMR食源性致病菌快速检测方法
CN103217449B (zh) * 2013-03-26 2016-02-24 南昌大学 一种基于顺磁纳米Fe-Ni合金探针间接富集的NMR食源性致病菌快速检测方法
EP3069127B1 (de) * 2013-11-13 2023-07-26 NanoNord A/S Verfahren zur quantitativen bestimmung von stickstoff in wässrigen flüssigkeiten
FR3039767B1 (fr) * 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
US11406721B2 (en) 2016-02-22 2022-08-09 The Regents Of The University Of California Compositions and methods for imaging cell populations
WO2023234979A2 (en) * 2021-12-20 2023-12-07 The Regents Of The University Of California High field magnetometry with hyperpolarized nuclear spins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49103693A (de) * 1973-02-02 1974-10-01
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4837604A (en) * 1986-04-18 1989-06-06 Hypres, Inc. Femtosecond three-terminal switch and vertical tunnel junction
US4875486A (en) * 1986-09-04 1989-10-24 Advanced Techtronics, Inc. Instrument and method for non-invasive in vivo testing for body fluid constituents
IE61448B1 (en) * 1987-06-23 1994-11-02 Hafslund Nycomed Innovation Improvements in and relating to magnetic resonance imaging
US5234680A (en) * 1989-07-31 1993-08-10 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI
US5236694A (en) * 1990-02-21 1993-08-17 The Board Of Regents, The University Of Texas System 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5100646A (en) * 1990-07-25 1992-03-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services NMR glomerular filtration test
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc

Also Published As

Publication number Publication date
FI941832A0 (fi) 1994-04-20
EP0621491B1 (de) 2002-07-24
JPH07374A (ja) 1995-01-06
IL109115A0 (en) 1994-06-24
EP0621491A2 (de) 1994-10-26
AU6061394A (en) 1994-10-27
EP0621491A3 (de) 1995-06-07
NO941485D0 (no) 1994-04-22
KR100359898B1 (ko) 2003-01-10
CN1094938A (zh) 1994-11-16
DE69431016D1 (de) 2002-08-29
FI941832A7 (fi) 1994-10-24
US5603917A (en) 1997-02-18
HUT69795A (en) 1995-09-28
CA2119345A1 (en) 1994-10-24
CZ89894A3 (en) 1995-02-15
IL109115A (en) 1997-07-13
HU9401166D0 (en) 1994-07-28
KR940023442A (ko) 1994-11-17
DE69431016T2 (de) 2003-03-27
ZA942781B (en) 1995-01-05
US5468467A (en) 1995-11-21
CA2119345C (en) 1999-10-26
NO941485L (no) 1994-10-24

Similar Documents

Publication Publication Date Title
ATE221208T1 (de) VERFAHREN ZUR ßIN-VIVOß-MESSUNG DER KONZENTRATION VON XENOBIOTISCHEN VERBINDUNGEN MITTELS MAGNETISCHER KERNRESONANZ
Pan et al. Intracellular pH in human skeletal muscle by 1H NMR.
Lindeman et al. A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo p h
DE69111798D1 (de) 19f-markierte verbindungen zur verwendung als nmr-bilderzeugungs- und spektroskopiermittel.
DE59009716D1 (de) Verfahren zur Prüfung der Qualität und der Qualitätsänderungen von biologischen Systemen und mit ihnen wechselwirkenden organisch-chemischen Verbindungen mittels Messung der ultraschwachen Photonenemission.
DE69127785D1 (de) System zur Bestimmung der Körperaktivität eines Patienten durch Messung der Blut-Sauerstoff-Sättigung
DE69920940D1 (de) Verfahren zur überwachung der proteasomeinhibitorarzneimitteleffekte
ATE549637T1 (de) Verfahren zur untersuchung des verhaltens einer testsubstanz mittels nmr-spektroskopie
ATE184703T1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE60142788D1 (de) Verfahren zur untersuchung einer probe mittels magnetischer resonanz unter verwendung eines kernspinpolarisierten kontrastmittels
Jordan et al. Contribution of oxygenation to BOLD contrast in exercising muscle
DE60225903D1 (de) In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen
ATE106751T1 (de) Mittel für magnetische resonanzbilderzeugung.
DE3875826D1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
ATE470152T1 (de) Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln
Kintner et al. In vivo microdialysis of 2‐deoxyglucose 6‐phosphate into brain: a novel method for the measurement of interstitial pH using 31P‐NMR
ATE415636T1 (de) Verfahren, programm und gerät zur aufnahme von mr-bilddaten eines sich bewegenden organs
Brooks et al. On-line PO2 and PN2O analysis with an in vivo catheter electrode
ATE228328T1 (de) Anordnung zur vorzugsweise ambulanten messung mittels elektroden
DE59912500D1 (de) Computer zur auswertung von signalen aus der kernmagnetischen resonanztomographie sowie mit dem computer ausgestatteter kernresonanztomograph
DE68922686D1 (de) Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
RU94013446A (ru) Способ определения концентрации ямр-детектируемого соединения-ксенобиотика in vivo
Yamane et al. Optical isometric force transducer for measurement of rat skeletal muscle contraction in the NMR spectrometer
Anaemia Comparative Sequence Assessment of Optimised T2 and T2* Sequences
Parkes Measuring blood perfusion in the brain using Arterial spin labelled MRI

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties